- Report
- January 2024
- 126 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- February 2024
- 81 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- January 2024
- 121 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- October 2023
- 107 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- February 2025
- 110 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- January 2025
- 78 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- January 2025
- 93 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- October 2024
- 105 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- October 2024
- 104 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- October 2024
- 99 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- September 2024
- 79 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- August 2024
- 104 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- November 2023
- 101 Pages
Global
From €3500EUR$3,957USD£3,057GBP
- Report
- December 2024
- 79 Pages
United Kingdom
From €824EUR$870USD£696GBP
- Report
- October 2024
- 75 Pages
United States
From €1142EUR$1,205USD£964GBP
- Report
- November 2024
- 32 Pages
China
From €4733EUR$4,995USD£3,995GBP
- Report
- November 2024
Global
From €1421EUR$1,500USD£1,200GBP
- Book
- September 2018
- 137 Pages

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more